Previously we have shown that inhibition of replication of vesicular stomatitis virus in interferon-treated JLSV-11 cells is at least partly caused by impaired viral primary transcription. Here we report that subviral particles isolated from interferon-treated infected cells were deficient in mRNA synthesis in vitro compared with the particles isolated from untreated cells. This was due to the presence of an associated ribonuclease activity which hydrolyzed not only newly synthesized viral mRNAs but also exogenously added viral transcripts.
The detailed mechanism by which interferon (IFN) inhibits the replication of a virus remains unclear despite extensive studies on the antiviral actions of IFN (6, 9) . We have been studying the underlying mechanisms by which IFN inhibits vesicular stomatitis virus (VSV) replication. Using a VSV temperature-sensitive mutant and two pairs of IFNsensitive and -resistant cell lines, we demonstrated that accumulation of VSV primary transcripts is inhibited by IFN-treatment of GM2767 and JLSV-11, two sensitive cell lines (2) . Since virus entry and uncoating are not affected under these conditions, it appears that viral primary transcription itself is impaired in IFN-treated cells. Here we report that VSV subviral particles isolated from IFN-treated JLSV-11 cells, which had been restricted to primary transcription conditions, synthesized less VSV mRNA in vitro than did similar particles isolated from untreated cells. Results are presented which suggest that this was caused by the presence of a ribonuclease activity associated with the subviral particles isolated from IFN-treated cells.
We have previously described procedures for culturing JLSV-11 cells and infecting them with VSV (2), methods for VSV mRNA transcription in vitro, and analyses of the products (4) and methods for the preparation of mRNA of the phosphoprotein (NS) of VSV in vitro by using a plasmid vector containing NS cDNA inserted behind a bacteriophage SP6 transcriptional promoter (3) . IFN treatment was done for 18 h with 500 U of a partially purified mouse beta IFN preparation per ml (specific activity, 2 x 108 U of protein per mg) purchased from Lee BioMolecular, San Diego, Calif. VSV subviral particles (RNPs) were isolated from IFNtreated or untreated infected JLSV-11 cells (10) . For this purpose, cells were grown in roller bottles; at 50% confluency the cells were treated with 500 U of mouse IFN per ml for 18 h, if desired, and infected with VSV at a multiplicity of infection of 10 in the presence of 100 ,uM anisomycin, as described before (2 mRNA was synthesized by RNP1 compared with that synthesized by RNPC, but the extent of inhibition varied from 3-to 10-fold, depending on the actual concentration of RNPs in the reaction mixture.
When a high concentration of RNPs of another lot was used for in vitro transcription, the amount of VSV mRNAs synthesized decreased with increasing amounts of RNPJ (Fig. 3A, lanes 3 and 4) Direct demonstration of RNPI-associated RNase activity is documented (Fig. 4) . In these experiments, we used VSV NS mRNA transcripts synthesized by SP6 RNA polymerase from an NS cDNA-containing plasmid vector (3) . RNA was extensively hydrolyzed (83%) in the presence of RNP1 compared with that in the presence of RNPC (19%) (Fig. 4A) . RNase reaction in the presence or in the absence of ribonucleoside triphosphates did not alter the extent of mRNA degradation (data not shown). The RNase activity was found to be tightly associated with RNP,. This was demonstrated when RNP, pellets were suspended in cell homogenization buffer and resedimentated; the RNase activity still remained associated with the pellet, and the supernatant was virtually free of RNase activity (Fig. 4B ). No such activity was A. (5, 7) and by reovirions to which extract of IFN-treated cells has been added (1) . Wallach and Revel (11) have reported trapping 2',5'-oligoadenylate synthetase in VSV and murine leukemia virus particles released from IFN-treated cells (11) . Activation of the RNase activity associated with RNP1 by 2',5'-oligoadenylate synthesis in situ is however unlikely, since this RNase could hydrolyze mRNA in the absence of any added ATP. Irrespective of whether this RNase activity is related to RNase L activity, the important mechanistic question is whether it can account for the inhibition of VSV primary transcription observed in IFN-treated cells in vivo. Experiments to clarify these issues are in progress.
